Synergistic activity of polymyxin B combined with vancomycin against carbapenem-resistant and polymyxin-resistant Acinetobacter baumannii: first in vitro study | Zendy

Danielle Rosani Shinohara | Zendy; Thatiany Cevallos Menegucci | Zendy; Nayara Helisandra Fedrigo | Zendy; Letícia Busato Migliorini | Zendy; Floristher Elaine Carrara-Marroni | Zendy; Márcia Maria dos Anjos | Zendy; Celso Luíz Cardoso | Zendy; Sheila Alexandra Belini Nishiyama | Zendy; Maria Cristina Bronharo Tognim | Zendy

Open Access

Synergistic activity of polymyxin B combined with vancomycin against carbapenem-resistant and polymyxin-resistant Acinetobacter baumannii: first in vitro study

Author(s) -

Danielle Rosani Shinohara,

Thatiany Cevallos Menegucci,

Nayara Helisandra Fedrigo,

Letícia Busato Migliorini,

Floristher Elaine Carrara-Marroni,

Márcia Maria dos Anjos,

Celso Luíz Cardoso,

Sheila Alexandra Belini Nishiyama,

Maria Cristina Bronharo Tognim

Publication year - 2019

Publication title -

journal of medical microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.91

H-Index - 117

eISSN - 1473-5644

pISSN - 0022-2615

DOI - 10.1099/jmm.0.000920

Subject(s) - acinetobacter baumannii , polymyxin , microbiology and biotechnology , polymyxin b , vancomycin , carbapenem , acinetobacter , in vitro , antibiotics , biology , medicine , bacteria , pseudomonas aeruginosa , staphylococcus aureus , biochemistry , genetics

The effect of a combination of polymyxin B (PMB) and vancomycin (VAN) was assessed against six Acinetobacter baumannii clinical isolates belonging to six different clusters (three PMB-susceptible and three PMB-resistant).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research